iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://www.ncbi.nlm.nih.gov/omim/605375
Entry - #605375 - EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3 - OMIM
# 605375

EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
1q21.3 Epilepsy, nocturnal frontal lobe, 3 605375 3 CHRNB2 118507

TEXT

A number sign (#) is used with this entry because of evidence that nocturnal frontal lobe epilepsy-3 (ENFL3) is caused by heterozygous mutation in the gene encoding the beta-2 nicotinic acetylcholine receptor (nAChR) subunit (CHRNB2; 118507) on chromosome 1q21.


Description

Clustered attacks of epileptic episodes originating from the frontal lobe during sleep represent the main manifestation of autosomal dominant frontal lobe epilepsy (ENFL, ADNFLE) (summary by De Fusco et al., 2000).

For a general phenotypic description of autosomal dominant nocturnal frontal lobe epilepsy, see 600513.


Clinical Features

Gambardella et al. (2000) reported a large 3-generation Italian family segregating autosomal dominant nocturnal frontal lobe epilepsy. The age at onset of seizures was around 9 years of age and all affected individuals manifested nocturnal partial seizures of frontal lobe origin.


Mapping

In a large Italian family segregating ADNFLE, Gambardella et al. (2000) excluded linkage to known loci on chromosome 20 (600513) and chromosome 15 (603204) and established linkage to chromosome 1.


Inheritance

The transmission pattern of ADNFLE in the family reported by Gambardella et al. (2000) and De Fusco et al. (2000) was consistent with autosomal dominant inheritance with incomplete penetrance.


Molecular Genetics

In affected members of the Italian family with ADNFLE reported by Gambardella et al. (2000), De Fusco et al. (2000) identified a heterozygous mutation in the CHRNB2 gene (V287L; 118507.0001). Eight members were affected and 5 were asymptomatic, suggesting incomplete penetrance of the disorder.

In affected members of a Scottish family with ADNFL3, Phillips et al. (2001) identified a different heterozygous mutation at the same codon in the CHRNB2 gene (V287M; 118507.0002).


Animal Model

Manfredi et al. (2009) developed and characterized a mouse model of ENFL3 carrying the V287L mutation (118507.0001) of the CHRNB2 gene. Mice expressing mutant receptors showed a spontaneous epileptic phenotype by electroencephalography with very frequent interictal spikes and seizures. Expression of the mutant protein was driven by a neuronal-specific tetracycline-controlled promoter, which allowed reversible planned silencing of transgene expression. Restricted silencing during development was sufficient to prevent the occurrence of epileptic seizures in adulthood. Manfredi et al. (2009) hypothesized that mutant nicotinic receptors are responsible for abnormal formation of neuronal circuits and/or long-lasting alteration of network assembly in the developing brain, thus leading to epilepsy.


REFERENCES

  1. De Fusco, M., Becchetti, A., Patrignani, A., Annesi, G., Gambardella, A., Quattrone, A., Ballabio, A., Wanke, E., Casari, G. The nicotinic receptor beta-2 subunit is mutant in nocturnal frontal lobe epilepsy. Nature Genet. 26: 275-276, 2000. [PubMed: 11062464, related citations] [Full Text]

  2. Gambardella, A., Annesi, G., De Fusco, M., Patrignani, A., Aguglia, U., Annesi, F., Pasqua, A. A., Spadafora, P., Oliveri, R. L., Valentino, P., Zappia, M., Ballabio, A., Casari, G., Quattrone, A. A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chromosome 1. Neurology 55: 1467-1471, 2000. [PubMed: 11094099, related citations] [Full Text]

  3. Manfredi, I., Zani, A. D., Rampoldi, L., Pegorini, S., Bernascone, I., Moretti, M., Gotti, C., Croci, L., Consalez, G. G., Ferini-Strambi, L., Sala, M., Pattini, L., Casari, G. Expression of mutant beta-2 nicotinic receptors during development is crucial for epileptogenesis. Hum. Molec. Genet. 18: 1075-1088, 2009. [PubMed: 19153075, related citations] [Full Text]

  4. Phillips, H. A., Favre, I., Kirkpatrick, M., Zuberi, S. M., Goudie, D., Heron, S. E., Scheffer, I. E., Sutherland, G. R., Berkovic, S. F., Bertrand, D., Mulley, J. C. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am. J. Hum. Genet. 68: 225-231, 2001. [PubMed: 11104662, images, related citations] [Full Text]


George E. Tiller - updated : 10/26/2009
Cassandra L. Kniffin - updated : 6/4/2002
Creation Date:
Victor A. McKusick : 10/31/2000
carol : 01/09/2024
carol : 01/08/2024
carol : 11/16/2016
carol : 01/08/2013
carol : 3/23/2012
carol : 3/21/2012
carol : 3/21/2012
wwang : 11/10/2009
terry : 10/26/2009
carol : 6/4/2002
alopez : 11/1/2000
alopez : 10/31/2000

# 605375

EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3


ORPHA: 98784;   DO: 0060684;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
1q21.3 Epilepsy, nocturnal frontal lobe, 3 605375 3 CHRNB2 118507

TEXT

A number sign (#) is used with this entry because of evidence that nocturnal frontal lobe epilepsy-3 (ENFL3) is caused by heterozygous mutation in the gene encoding the beta-2 nicotinic acetylcholine receptor (nAChR) subunit (CHRNB2; 118507) on chromosome 1q21.


Description

Clustered attacks of epileptic episodes originating from the frontal lobe during sleep represent the main manifestation of autosomal dominant frontal lobe epilepsy (ENFL, ADNFLE) (summary by De Fusco et al., 2000).

For a general phenotypic description of autosomal dominant nocturnal frontal lobe epilepsy, see 600513.


Clinical Features

Gambardella et al. (2000) reported a large 3-generation Italian family segregating autosomal dominant nocturnal frontal lobe epilepsy. The age at onset of seizures was around 9 years of age and all affected individuals manifested nocturnal partial seizures of frontal lobe origin.


Mapping

In a large Italian family segregating ADNFLE, Gambardella et al. (2000) excluded linkage to known loci on chromosome 20 (600513) and chromosome 15 (603204) and established linkage to chromosome 1.


Inheritance

The transmission pattern of ADNFLE in the family reported by Gambardella et al. (2000) and De Fusco et al. (2000) was consistent with autosomal dominant inheritance with incomplete penetrance.


Molecular Genetics

In affected members of the Italian family with ADNFLE reported by Gambardella et al. (2000), De Fusco et al. (2000) identified a heterozygous mutation in the CHRNB2 gene (V287L; 118507.0001). Eight members were affected and 5 were asymptomatic, suggesting incomplete penetrance of the disorder.

In affected members of a Scottish family with ADNFL3, Phillips et al. (2001) identified a different heterozygous mutation at the same codon in the CHRNB2 gene (V287M; 118507.0002).


Animal Model

Manfredi et al. (2009) developed and characterized a mouse model of ENFL3 carrying the V287L mutation (118507.0001) of the CHRNB2 gene. Mice expressing mutant receptors showed a spontaneous epileptic phenotype by electroencephalography with very frequent interictal spikes and seizures. Expression of the mutant protein was driven by a neuronal-specific tetracycline-controlled promoter, which allowed reversible planned silencing of transgene expression. Restricted silencing during development was sufficient to prevent the occurrence of epileptic seizures in adulthood. Manfredi et al. (2009) hypothesized that mutant nicotinic receptors are responsible for abnormal formation of neuronal circuits and/or long-lasting alteration of network assembly in the developing brain, thus leading to epilepsy.


REFERENCES

  1. De Fusco, M., Becchetti, A., Patrignani, A., Annesi, G., Gambardella, A., Quattrone, A., Ballabio, A., Wanke, E., Casari, G. The nicotinic receptor beta-2 subunit is mutant in nocturnal frontal lobe epilepsy. Nature Genet. 26: 275-276, 2000. [PubMed: 11062464] [Full Text: https://doi.org/10.1038/81566]

  2. Gambardella, A., Annesi, G., De Fusco, M., Patrignani, A., Aguglia, U., Annesi, F., Pasqua, A. A., Spadafora, P., Oliveri, R. L., Valentino, P., Zappia, M., Ballabio, A., Casari, G., Quattrone, A. A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chromosome 1. Neurology 55: 1467-1471, 2000. [PubMed: 11094099] [Full Text: https://doi.org/10.1212/wnl.55.10.1467]

  3. Manfredi, I., Zani, A. D., Rampoldi, L., Pegorini, S., Bernascone, I., Moretti, M., Gotti, C., Croci, L., Consalez, G. G., Ferini-Strambi, L., Sala, M., Pattini, L., Casari, G. Expression of mutant beta-2 nicotinic receptors during development is crucial for epileptogenesis. Hum. Molec. Genet. 18: 1075-1088, 2009. [PubMed: 19153075] [Full Text: https://doi.org/10.1093/hmg/ddp004]

  4. Phillips, H. A., Favre, I., Kirkpatrick, M., Zuberi, S. M., Goudie, D., Heron, S. E., Scheffer, I. E., Sutherland, G. R., Berkovic, S. F., Bertrand, D., Mulley, J. C. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am. J. Hum. Genet. 68: 225-231, 2001. [PubMed: 11104662] [Full Text: https://doi.org/10.1086/316946]


Contributors:
George E. Tiller - updated : 10/26/2009
Cassandra L. Kniffin - updated : 6/4/2002

Creation Date:
Victor A. McKusick : 10/31/2000

Edit History:
carol : 01/09/2024
carol : 01/08/2024
carol : 11/16/2016
carol : 01/08/2013
carol : 3/23/2012
carol : 3/21/2012
carol : 3/21/2012
wwang : 11/10/2009
terry : 10/26/2009
carol : 6/4/2002
alopez : 11/1/2000
alopez : 10/31/2000